ClinicalTrials.gg
Drug

FS 069 clinical trials

studies test it
19
open now
0
in phase 3
1
first study started
2002

How each study uses FS 069 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Optison
14
Perflutren Protein-Type A Microspheres
6
Perflutren Protein-Type A Microspheres Injectable Suspension
2

Studies by the year they started

19 studies that test it; most in 2015 (4)

Studies that test FS 069, by start year
YearStudies
20021
20061
20081
20091
20111
20122
20133
20141
20154
20171
20201
20211
20221

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
6
Phase 3
1
Phase 4
5
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 4 · Other 15

GE Healthcare (4) · Thomas Jefferson University (3) · University of Nebraska (2) · Mayo Clinic (2) · University of Utah (1) · Kassa Darge (1) · M.D. Anderson Cancer Center (1) · David Mooney (1)

Often tested with

Tested in the same studies.

Perflutren (2) · Regadenoson (1) · Sulfur Hexafluoride (1)

Studies

Open first, then newest update. How each study uses FS 069 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Codes

What other systems call FS 069 · ClinicalTrials.gg INT003903

  • MeSH (NLM) C099458FS 069One source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.